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Article focus
  extra cellular matrix proteins and growth 
factors leaking from a bone cavity, along 
with a ceramic biomaterial, can synergisti-
cally enhance the process of ectopic ossifi-
cation. the overlaying muscle acts as an 
osteoinductive niche, which provides the 
required cells to be used to transform into 
bone.
Key messages
  A bone defect treated with a ceramic bio-
material undergoes local remodeling but 
can also lead to bone formation in the mus-
cle immediately covering the biomaterial.
  c2c12 muscle cells differentiate into bone-
like cells when seeded on the biomaterial 
(calcium sulphate/hydroxyapatite), dem-
onstrating the osteoinductive behaviour of 
the material.
  roS 17/2.8 bone cells produce pro-osteo-
genic proteins bMP-2 and bMP-7, which 
can lead to differentiation of muscle cells.
Strengths and limitations
  this study describes a possible molecular 
mechanism behind ectopic bone formation 
when a surgically operated bone defect is 
treated with a biomaterial covered with a 
free muscle flap.
Muscle as an osteoinductive niche 
for local bone formation with the 
use of a biphasic calcium sulphate/
hydroxyapatite biomaterial
Objectives
We have observed clinical cases where bone is formed in the overlaying muscle covering surgi-
cally created bone defects treated with a hydroxyapatite/calcium sulphate biomaterial. our 
objective was to investigate the osteoinductive potential of the biomaterial and to determine if 
growth factors secreted from local bone cells induce osteoblastic differentiation of muscle cells.
Materials and Methods
We seeded mouse skeletal muscle cells c2c12 on the hydroxyapatite/calcium sulphate bio-
material and the phenotype of the cells was analysed. To mimic surgical conditions with 
leakage of extra cellular matrix (ecM) proteins and growth factors, we cultured rat bone 
cells Ros 17/2.8 in a bioreactor and harvested the secreted proteins. The secretome was 
added to rat muscle cells L6. The phenotype of the muscle cells after treatment with the 
media was assessed using immunostaining and light microscopy.
Results
c2c12 cells differentiated into osteoblast-like cells expressing prominent bone markers 
after seeding on the biomaterial. The conditioned media of the Ros 17/2.8 contained 
bone morphogenetic protein-2 (BMp-2 8.4 ng/mg, standard deviation (sd) 0.8) and 
BMp-7 (50.6 ng/mg, sd 2.2). In vitro, this secretome induced differentiation of skeletal 
muscle cells L6 towards an osteogenic lineage.
Conclusion
extra cellular matrix proteins and growth factors leaking from a bone cavity, along with a ceramic 
biomaterial, can synergistically enhance the process of ectopic ossification. The overlaying 
muscle acts as an osteoinductive niche, and provides the required cells for bone formation.
cite this article: Bone Joint Res 2016;5:500–511.
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  In future, we would perform additional studies in a 
larger animal model to verify our findings.
Introduction
one of the major challenges in modern orthopaedic sur-
gery is to replace and regenerate bone. there is an 
increasing demand for bone substitutes that can aug-
ment and repair bone defects following trauma, infection 
or tumour resection.1 the ideal bone graft should be 
non-immunogenic, osteoinductive, osteoconductive and 
osteogenic.2-8 Autologous bone fulfills these require-
ments but the availability is limited.1,4,9-12 Furthermore, 
surgery is required for its harvesting, which in turn is 
associated with donor site morbidity and in the worst 
case, infection. to overcome these drawbacks, synthetic 
bone grafts have been developed: mainly ceramic, poly-
meric or composite.1,13 Ideally, these materials should 
not just act as structural support but should also initiate 
and enhance tissue regeneration.12,14
various studies have shown that the chemistry and 
surface geometry of the biomaterial in contact with mes-
enchymal cells play a crucial role in differentiating induc-
ible cells from bone cells.15-20 Muscle cells such as c2c12 
(murine skeletal myoblasts) have been used for studying 
this mechanism of differentiation.17,21 Additionally, bone 
matrix contains bone morphogenetic proteins (bMPs) 
that play an important role in the mineralisation of tis-
sues, both ectopic and entopic.7,22,23 It is also known that 
muscle cells are capable of differentiating into osteogenic 
lineages when stimulated with signaling molecules or 
mineralised milieu.24
there is a clinical need for less invasive procedures with 
injectable materials that set in vivo, to reduce surgical inva-
siveness, enabling a shorter hospitalisation and quicker 
rehabilitation. cerament (hydroxyapatite (HA)-calcium 
sulphate (cS)) (boneSupport Ab, lund, Sweden) is an 
injectable composite biomaterial consisting of particles of 
HA and cS hemihydrates. this powder composite is mixed 
with a liquid solution that leads to the setting of a resorb-
able calcium sulphate dihydrate, embedding and binding 
the unreacted HA particles.25 recently, the first antibiotic-
containing injectable bone substitute, cerament G 
(HA-cS-gentamicin (G)) (boneSupport Ab), was approved 
for clinical use in europe. During the initial phase of clinical 
testing, rapid bone regeneration was observed when the 
hydroxyapatite/calcium sulphate biomaterial was used to 
fill cavities after excision of osteomyelitis or resected bone 
tumours. In a few cases, bone was also found in the over-
laying muscle. We hypothesise that the biomaterial can 
induce muscle cells to differentiate into osteoblasts at the 
interface between the muscle and the biomaterial. We also 
hypothesise that the bone induction proteins harvested 
from bone cell cultures could induce differentiation of 
muscle into bone, thereby mimicking the clinical scenario 
in a controlled experimental environment.
Materials and Methods
Materials. cerament (HA-cS) and cerament G (HA-cS-G) 
were supplied by bone Support Ab, lund, Sweden. 
3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium 
bromide (Mtt), Sigmafast p-Nitrophenyl phosphate 
(pNPP), Dulbecco's Modified eagle's Medium - high 
glucose (DMeM - HG), foetal bovine serum (FbS), anti-
biotic cocktail (penicillin-streptomycin), trIzol reagent 
and primers for real-time polymerase chain reaction 
(rt-Pcr) were purchased from Sigma Aldrich (St. louis, 
Missouri). Mouse monoclonal colI, monoclonal oPN 
and rabbit polyclonal runX2, polyclonal ocN, goat 
anti-rabbit Alexa Fluor 488 (AF488) and goat anti-
mouse cy3 secondary antibodies were purchased from 
Santa cruz biotechnology Inc. (Paso robles, california) 
and Sigma Aldrich. Mouse monoclonal colI, ocN and 
oPN and polyclonal bone sialoprotein (bSP) antibodies, 
DrAQ5, goat anti-mouse Alexa Fluor 488 (AF488) were 
procured from Abcam (cambridge, United Kingdom). 
rt-Pcr reagents were purchased from thermo Scientific 
(Waltham, Massachusetts). rat bMP-2 and bMP-7 
enzyme-linked immunoabsorbance assay (elISA) kits 
were purchased from Abnova Inc. (taipei city, taiwan 
and Qayee-bio, Shanghai, china) respectively. All basic 
reagents (such as sodium chloride) were of high purity 
and purchased from recognised suppliers.
Clinical observations using hA-CS and hA-CS-G: uncon-
tained bone defect after tumour resection. A 35-year-old 
man underwent wide resection of a low-grade periosteal 
chondrosarcoma (Fig. 1) from his right posterior distal 
femur in october 2013. Joint-preserving multiplanar 
femoral osteotomies and placement of a lateral locked 
plate (lISS, Synthes, West chester, Pennsylvania), to 
stabilise the anterior cortical remnant, were performed 
with the help of intra-operative 3D ct-based computer 
navigation (o-arm and Medtronic Stealth, Medtronic, 
Dublin, Ireland). this was followed by bone defect 
reconstruction with 20 ml of demineralised bone matrix 
(20 ml, DbX, Synthes), fashioned into a shallow wall 
around the entire circumference of the resection area, 
before implantation of 30 ml HA – cS - G and 36 ml of 
HA-cS into the remaining bone defect. the hardened 
bone substitute was covered with collagen sponges 
(Spongostan, Ferrosan, Søborg, Denmark) and residual 
overlying musculature, before tight closure in layers 
over two deep drains.
Chronic osteomyelitis. A 65-year-old woman, with well 
controlled epilepsy, asthma and eczema, who was a 
smoker, presented with a 44-year history of recurrent 
osteomyelitis after a closed distal tibial fracture, initially 
treated with internal fixation. the fracture healed but 
with a persistent sinus and a constant purulent discharge 
for more than 20 years (Fig. 2a). two previous attempts 
to excise and eradicate the infection had been unsuccess-
ful. MrI revealed a cierny-Mader type 3b osteomyelitis,26 
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involving the medullary bone and adjacent cortex 
(Fig. 2b). In May 2013, the infected bone and the soft 
tissue were radically excised and 10 ml of HA-cS-G was 
implanted in the resected area (Fig. 2c). Soft-tissue recon-
struction was carried out using a free gracilis muscle flap 
and skin graft.
Material preparation for in vitro experiments. the two 
types of bone substitutes, HA-cS and HA-cS-G, were 
mixed as per supplier’s guidelines (bone Support Ab) to 
form a homogenous paste. the paste was poured into 
a disc-shaped mould, 8 mm in diameter and 2 mm in 
height, and allowed to set for 30 minutes. thereafter, 
time course observations of bone defect from a wide periosteal chondrosarcoma resection, treated with hydroxyapatite-calcium sulphate (HA-cS) and HA-cS-
gentamicin (G) biomaterial. Panels (a), (b) and (c) represent pre-operative radiograph, MrI and Pet-ct images of the tumour (red box), while panel (d) shows 
the bone defect filled with the biomaterial (red box) post-operatively. Arrows in the radiographs in panel (e) indicate bone formation in areas of direct muscle 
contact with HA-cS and HA-cS-G six weeks post-operatively, while arrows in panel (f) indicate reduced opacity of the regenerate at five months. Arrows in 
ct images in panels (g) and (h), respectively, indicate bone formation in the treated area posterior to the distal supracondylar region at three months post-
operatively, progressively remodeling at ten months. Panels (i) through to (l) represent 3D reconstructions of ct images at three (i), five (j) and ten months (k), 
(l) showing progressive bone remodeling around the defect.
 Fig. 1a Fig. 1b Fig. 1c Fig. 1d
 Fig. 1e Fig. 1f Fig. 1g Fig. 1h
 Fig. 1i Fig. 1j Fig. 1k Fig. 1l
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discs with the set material were taken out of the mould 
and were used for further analysis.
Cell culture. Mouse myoblast c2c12 cells were cultured 
in DMeM supplemented with 10% FbS and antibiotics. 
cells were kept in an incubator with 95% air and 5% co2. 
For the proliferation and functionality experiments, 1 × 
105 cells were seeded onto the HA-cS and HA-cS-G discs, 
while for immunofluorescence staining and reverse tran-
scription polymerase chain reaction (rt - Pcr), 1 × 106 
cells were seeded onto the HA-cS discs only. the rat skel-
etal muscle myoblast cell line l6 was cultured in DMeM 
with a high glucose (4500 mg/l) mixture supplemented 
with 10% by volume (v/v) FbS and 1% v/v antibiotic 
cocktail consisting of penicillin-streptomycin. cells were 
passaged at 80% confluence and were used at second 
passage after revival. cell viability before experiments 
was evaluated using the trypan blue exclusion method, 
where dead cells stain blue and are excluded from the 
count.
In order to mimic in vivo conditions that lead to bone 
formation in the muscle tissue, we harvested osteoblast 
cell-derived proteins from an expanded cell culture of 
roS 17/2.8 osteoblastic cells. cells were allowed to pro-
liferate in culture flasks supplemented with complete 
medium and 5% v/v serum for a period of three days. the 
secreted bone active proteins in the medium were col-
lected while the cells were passaged again to repeat the 
procedure.
to ensure differentiation of muscle cells into osteoblast- 
like cells, we used the rat muscle cell line l6. the cells 
were allowed to grow to 80% confluence, after which 
they were either supplied with low serum (5% v/v) com-
plete medium or a mixture of complete medium (low 
serum) and harvested osteoblast cell medium in an equal 
ratio by volume. the cells were allowed to grow for a 
period of ten or 12 days and were analysed using differ-
ent techniques outlined below to confirm a shift in their 
phenotype.
Microscopic analysis. Surface morphology of the materi-
als and adherence of the c2c12 cells on the surface of 
HA-cS and HA–cS-G discs were analysed using scan-
ning electron microscopy. Materials were dehydrated 
time course observations from resected osteomyelitis treated with hydroxyapatite-calcium sulphate-gentamicin (HA-cS-G) biomaterial. Panel (a) is a digital 
image of the chronic osteomyelitis area of the tibia with visible wound as indicated by the arrow. Panel (b) represents a pre-operative MrI image used for 
diagnosis of osteomyelitis with white arrows emphasising the infected area. radiograph in panel (c) represents the infected area filled with 10 ml of HA-cS-G 
post-operatively as indicated by white arrows while arrows in panel (d) indicate mineralisation in the overlaying muscle flap, four weeks post-operatively. Panel 
(e) represents a radiograph taken seven months post-operatively with arrows representing the resorbed bone previously observed at four weeks, while panel 
(f) represents a digital image of the healed wound seven months post-operatively.
 Fig. 2a Fig. 2b Fig. 2c
 Fig. 2d Fig. 2e Fig. 2f
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by gradient ethanol treatment, vacuum dried overnight 
and gold coated (Sputter coater, cressington Watford, 
United Kingdom). For analysing the cell adherence on the 
biomaterial surface, cells were seeded on both the mate-
rials i.e. HA-cS and HA–cS–G. the cells were allowed to 
grow for three days. thereafter, glutaraldehyde (2.5 %) 
was used to fix all of the cells on the surface. Steps fol-
lowing fixation were the same as were used for sample 
preparation for surface morphology analysis as described 
above with an exception of gold coating. Furthermore, 
attachment of cells on the HA-cS and HA-cS-G discs was 
analysed using 4’,6-diamidino-2-phenylindole (DAPI) 
staining.27
Cell proliferation assay. cell proliferation on both the 
materials was evaluated using Mtt assay at regular 
time intervals. briefly, the DMeM media in the wells was 
removed, and cell-seeded biomaterial discs were washed 
using phosphate buffer saline (PbS). thereafter, DMeM 
media, without FbS, containing Mtt (0.5 mg/ml) was 
added in the wells with an incubation time of five hours. 
Furthermore, this solution was removed and dimethyl 
sulfoxide (DMSo) was added. the samples were incu-
bated for 20 minutes at 37°c. the coloured solution 
formed was collected and absorbance was measured 
spectrophotometrically at 570 nm.28
cell proliferation analysis in the cell medium experi-
ments using l6 cells was done in a similar manner, and a 
cell density of 5 × 104 cells/well was used. the prolifera-
tion of myotubes was analysed by microscopy, and mult-
inucleated and elongated cells were considered to be 
myotubes.
Alkaline phosphatase assay. Sigmafast para-Nitrophenyl-
phosphate (pNPP) (Sigma Aldrich) tablets were used 
to prepare pNPP substrate solution, using the protocol 
provided by the manufacturer. the media were removed 
from the wells, and samples were washed using PbS 
buffer. the samples were then incubated with pNPP 
substrate solution for two hours in the co2 incubator at 
37°c, and absorbance was measured at 405 nm.28
Immunofluorescence staining for osteogenic markers. the 
osteoinductive potential of the HA-cS biomaterial was 
observed using immunofluorescence staining. the seeded 
cells were cultured in non-osteogenic medium for dif-
ferent time points and stained to detect the presence of 
different markers including runt-related transcription fac-
tor-2 (rUNX2), osteopontin (oPN), osteocalcin (ocN) 
and collagen type I (col I) over the period of 21 days. 
to confirm the differentiation of l6 muscle cells into 
osteoblast-like cells, we immunostained cells in both 
groups for various osteoblastic markers col I, ocN, oPN 
and bone sialoprotein (bSP). cells were allowed to grow 
in culture flasks for a period of ten days in a complete 
medium with osteoblast-harvested bone active proteins 
or low serum. the cells were trypsinised and seeded on 
four-well chamber slides and allowed to proliferate with 
the same medium for a further 48 hours. on the day of 
staining (day 12), cells were fixed using 4% formaldehyde 
for ten minutes followed by membrane permeabilisation 
using 0.1% v/v triton x-100 for five minutes. cells were 
immediately blocked using 5% goat serum for one hour 
and incubated with respective primary antibodies for 
two hours at room temperature. Slides were washed five 
times with phosphate buffer saline with tween-20 (PbSt), 
followed by incubation in secondary antibody (labelled 
AF488) for one hour followed by five more washes. the 
slides were counterstained using DrAQ5 for five min-
utes and washed twice for five minutes each. After dry-
ing, the slides were cleared, mounted and allowed to dry 
overnight before analysis. the cells were analysed on a 
Zeiss confocal microscope (carl Zeiss AG, oberkochen, 
Germany) at different magnifications.
RNA extraction and RT-PCR. the discs of HA-cS were 
seeded with c2c12 cells at a concentration of 1 × 106 
cells/disc. the rNA was extracted using trIzol reagent, 
after in vitro culturing of cell-seeded discs for the time 
period of seven days and 21 days. cell-seeded discs were 
transferred from multiwell plates to microtubes after add-
ing 1 ml of trIzol reagent. thereafter, rNA was isolated 
by following the protocol supplied by the manufacturer. 
complimentary DNA (cDNA) was synthesised by incu-
bating isolated rNA (20 µl) with 1 µl of oligo(dt) at 75°c 
for five minutes, followed by incubation in ice for five 
minutes. the cDNA mix, 4 µl of buff rt, 1 µl of rtase, 0.5 
µl of rI (rnase inhibitor) and 2 µl of dNtP mix were then 
added. rt-Pcr was conducted to evaluate the expres-
sion of various genes of the osteogenic lineage such as 
rUNX2, col I, bSP and ocN. the primer sequences of 
the genes are obtained from previous reports.29-31 As 
an endogenous control, expression of glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) was determined. 
A consecutive thermal cycle was used for DNA amplifica-
tion. Products of rt-Pcr were resolved on a 2.0% aga-
rose gel stained using ethidium bromide.
Morphological changes using light microscopy and hae-
matoxylin and eosin staining. the differentiation of 
muscle cells with the addition of osteoblast-harvested 
bone active proteins was analysed over a period of sev-
eral days. Morphological analysis was performed using 
both light microscopy and Haemotoxylin and eosin (H 
and e) staining. culture flasks were directly monitored 
using a light microscope at different magnifications. In 
order to perform H and e staining, cells were grown in 
four-well chamber slides and were fixed with 4% (w/v) 
formaldehyde for ten minutes. cells were hydrated with 
reducing ethanol gradient and stained with hematoxy-
lin for five minutes. excessive stain was washed off using 
running water, followed by counterstaining with eosin 
for two minutes. the slides were cleaned in xylene for 
five minutes, then mounted and dried overnight before 
imaging.
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Osteoblast secretome composition. In an attempt to 
detect various pro-osteoblastic proteins in the roS 
17/2.8 cell factory, we dialysed the harvested cell media 
against ultrapure water for a period of 48 hours using 
an 8 kDa dialysis membrane. After dialysing, the proteins 
were concentrated using freeze-drying for a period of 48 
hours. the dried protein fraction was later analysed using 
elISA for the detection and measurement of two impor-
tant bone active molecules bMP-2 and bMP-7.
Statistical analysis. Data from the Mtt and alkaline phos-
phatase (AlP) assay were analysed using unpaired t-test. 
A p value of < 0.05 was considered to be significant. Data 
from the Mtt assay and myotube numbers were anal-
ysed using a non-parametric, multiple t-test, and p < 0.05 
was considered statistically significant. Data are shown in 
triplicate with mean and standard deviation (sd).
Results
Clinical observations using hA-CS and hA-CS-G: uncon-
tained bone defect after tumour resection. the tumour 
was resected and filled with both HA-cS and HA-cS-G 
(Figs 1a to 1d). Post-operative recovery was protracted 
due to delayed wound healing in a small area in the pop-
liteal fossa and transient peroneal nerve neuropraxia, 
which took six months to fully subside. Immediate post-
operative radiographs demonstrated almost complete 
filling of the defect (Fig. 1d). A large radio-dense regener-
ate with a sclerotic rim and increasing lucency towards 
its centre had formed six weeks post-operatively (Fig. 1e). 
Gradual reduction in its overall size was observed at 
each subsequent follow-up radiograph, while the scle-
rotic rim intensified up to the three-month mark, before 
slowly regressing again over its central aspect (Fig. 1f). 
ct scans at three, five and ten months post-operatively 
showed increasing bone remodeling, most prominently 
in distal (Figs 1g and 1h) and medial femur (Figs 1i 
to 1l). clinically, the patient had normal range of move-
ment and was able to bear weight fully without pain 11 
months post-operatively.
Chronic osteomyelitis. the patient with recurrent osteo-
myelitis was treated with the gentamicin-eluting bone 
substitute (HA-cS-G) (Figs 2a to 2c). After surgery, she 
recovered well with complete wound healing and rapid 
mobilisation. bone cultures were positive for Enterobacter 
cloacae, sensitive to gentamicin. Intravenous ertapenem 
treatment was initiated for six weeks, followed by six 
weeks of oral trimethoprim. Post-operative radiographs 
(Fig. 2c) showed good initial filling of the bone cavity 
with HA-cS-G. At four weeks, opacity was observed in the 
muscle overlaying the tibia that appeared as a bone shell 
(Fig. 2d). the bone shell surrounding the muscle reduced 
in size by 13 weeks but became denser. the bone defect 
was fully remodeled and trabecular bone was observed 
in the tibial defect area as seen from the radiograph 
(Fig. 2e). the opacity in the muscle also disappeared after 
seven months (Fig. 2e). the wound healed well (Fig. 2f). 
At review, 13 months after surgery, the patient had recov-
ered, had no leg pain and the wound had healed with no 
discharge.
Microscopic analysis. the surface morphology of HA-cS 
and HA-cS-G discs were analysed using scanning elec-
tron microscopy, and both materials showed micropo-
rous structure with the size of the pores at the material 
surface in the range of 1 µm to 10 µm (Figs 3a and 3b). 
cells were present on the surface of the biomaterial discs 
after three days of seeding. the cells were attached and 
homogenously distributed on both discs of HA-cS and 
HA-cS-G (Figs 3c and 3d). this was further confirmed by 
staining of the cells with DAPI that revealed a similar type 
of distribution pattern where seeded cells had adhered 
to and were evenly distributed on the surface of material 
(Figs 3e and 3f).
Cell proliferation. cell proliferation on the HA-cS and 
HA-cS-G discs was analysed using Mtt assay in order 
to assess the biocompatibility of the biomaterials and to 
evaluate whether the addition of gentamycin incurs tox-
icity in this model. Similar results were observed in both 
biomaterials with or without gentamicin (Fig. 4a). After the 
initial increase in the cell population until the seventh day, 
the cell proliferation was suppressed and a decrease in cell 
population was observed at the later time points. on the 
Scanning electron microscopy (SeM) and cell material interactions. SeM 
images in panel (a) and (b) represent hydroxyapatite-calcium sulphate (HA-
cS) and HA-cS-gentamicin (G), respectively, at high magnification (3000×). 
SeM and microscopic analysis of c2c12 muscle myoblasts proliferating on 
HA-cS (c, e) and HA-cS-G (d, f) three days post-seeding.
 Fig. 3a Fig. 3b
 Fig. 3c Fig. 3d
 Fig. 3e Fig. 3f
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other hand, in the case of two-dimensional polystyrene tis-
sue culture plates, taken as a control, an increase in cell 
proliferation was observed until the fourteenth day, and 
thereafter proliferation declined. cells seeded on both the 
materials showed a similar profile of cell proliferation. No 
statistically significant difference in cell proliferation was 
found (p > 0.05). However, increased cell proliferation was 
found in the polystyrene tissue culture plate compared 
with HA-cS and HA-cS-G discs (p < 0.0001).
Alkaline phosphate assay. the result of the AlP assay 
is shown in Figure 4b. the biomaterials (HA-cS and 
HA-cS-G) showed an increase in AlP by the 14th day of 
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Fig. 4b
cell culture study on hydroxyapatite-calcium sulphate (HA-cS) and HA-cS-gentamicin (G) biomaterials using c2c12 cells via 3-(4.5-dimethylthiazol-2-yl)-
2.5-diphenyltetrazolium bromide (Mtt) and alkaline phosphatase (AlP) analysis. Panel (a) represents the proliferation pattern of c2c12 muscle myoblasts on 
HA-cS and HA-cS-G biomaterials over a period of five weeks post-seeding. cellular proliferation was assessed via Mtt assay with 2D polystyrene plates as a 
control for proliferation. Panel (b) represents alkaline phosphatase assay showing the level of AlP activity of c2c12 muscle myoblasts seeded on HA-cS and 
HA-cS-G compared with tissue culture plate over a period of 35 days. Unpaired t-test was used for statistical analysis and p < 0.05 was considered significant. 
Data are represented as mean and standard deviation and the samples were taken in triplicate (n = 3).
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cell seeding. thereafter, the values of AlP start decreasing 
with time. Within a time period of 14 days, cells seeded 
on both the HA-cS and HA-cS-G biomaterials showed 
an eightfold increase in AlP level when compared with 
polystyrene controls (p < 0.05). there was no statistically 
significant difference in the level of AlP between the two 
materials (p > 0.05). However, the level of AlP in the cells 
seeded on the polystyrene plate was less than that in the 
cells seeded on both biomaterials.
Immunofluorescence staining and RT-PCR. the presence of 
markers of mature osteoblasts was studied over the whole 
time period (Fig. 5). Immunofluorescence staining showed 
the presence of rUNX2 by the seventh day of cell seeding 
on the HA-cS disc. the presence of other markers of mature 
osteoblasts ocN, col I, and oPN (all Fig. 5a) were detected 
by the 21st day of cell seeding. Negative antibody controls 
are shown in Figure 5 (Isotype 1 and Isotype 2).
osteopromotive potential of HA-cS was further con-
firmed by rt-Pcr analysis of cells seeded on the material. 
results showed the presence of rUNX2 by the seventh 
day (Fig. 5b) and the presence of other osteoblastic mark-
ers such as col 1, bSP and ocN by the 21st day of cell 
seeding (Fig. 5c).
the differentiation of muscle cells into bone cells after 
the addition of the cell culture-produced bone active pro-
teins was confirmed using immunofluorescent staining 
 Fig. 5a Fig. 5c
Immunocytochemical and real-time polymerase chain reaction analysis of c2c12 muscle myoblasts seeded on hydroxyapatite-calcium sulphate (HA-cS) bio-
material. c2c12 cells seeded on HA-cS were analysed using immunocytochemistry to visualise osteogenic differentiation. cells were stained after a period of 
seven and 21 days post-seeding. the first row (a) shows the isotype control for goat anti-rabbit, Alexa Fluor 488 while the fourth row shows the isotype control 
for goat anti-mouse cy3 secondary antibodies. cells stained positive for osteogenic markers like rUNX2 (second row) at day seven, and polyclonal ocN (third 
row), col I (fifth row), and monoclonal oPN (sixth row), after 21 days post-seeding. Images in the left hand panels (all rows) indicate nuclear staining using 
4’,6-diamidino-2-phenylindole staining while images in the middle panels (all rows) indicate antibody-based detection of respective target proteins while right 
hand panels (all rows) depict respective merged images (all 50 μm). early onset of osteogenic differentiation was confirmed by the presence of the rUNX2 gene 
in c2c12 cells seeded on HA-cS after seven days (b). osteoblastic maturation (21 days post-seeding) of muscle cells was confirmed by the presence of osteo-
blastic gene coding for col I (lane 1), ocN (lane 2), polyclonal bone sialoprotein (lane 3), and housekeeping gene glyceraldehyde 3-phosphate dehydrogenase 
(lane 4) with control ladder in (c), lane 5.
Fig. 5b
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of cells in both groups for osteogenic markers such as 
col  I, ocN, oPN and bSP. Figure 6 (a to d) shows the 
immunopositive and transdifferentiated muscle cells 
transformed into osteoblast-like cells. the cells in the 
treated groups expressed osteogenic proteins such as col 
I, ocN, oPN and bSP at day 12, while cells in the control 
group fused together to form myotubes and did not 
express osteogenic proteins.
Morphological changes using light microscopy and hema-
toxylin and eosin staining. A time course morphologi-
cal difference was observed in cells treated with bone 
active proteins and the control groups. the cells in the 
control groups (Figs 6e to 6g) can be seen as elongated 
from as early as day one until the end of the experiment 
when compared with cells in the treated groups (Figs 6h 
to 6j). H and e staining clearly illustrates the structural 
differences between the cells with and without treat-
ment of growth factors (Figs 6g and 6j). In the case of 
controls, muscle cells differentiate into fused myotubes 
possessing a number of nuclei, while the cells in the 
group treated with growth factors remain uninucleated 
throughout the experiment. Moreover, the size of the 
cells is much smaller and possesses osteoblast-like mor-
phology in the case of treated cells.
effect of cell factory-derived bone active proteins on rat skeletal myoblast cell line l6. Immunocytochemical analysis of l6 muscle myoblasts treated with 
osteoblast-harvested bone active proteins using laser scanning confocal microscopy was carried out after a period of 12 days. cells stained positive for most 
prominent osteoblastic markers col I (a), polyclonal ocN (b), monoclonal oPN (c) and polyclonal bone sialoprotein (b). Nuclear staining (blue) was performed 
using DrAQ5. Scale bar indicates 10 μm. Images in panels € and (f) (4× magnification) represent light microscopy images of l6 cells in the control group taken 
one day and ten days post-seeding, fusing together to form myotubes as seen in panel (f). Panel (g) represents Haemotoxylin and eosin (H and e)-stained 
myotubes ten days after seeding (10× magnification) while the inset picture (g) provides a high-magnification (40×) visualisation of an individual cell contain-
ing multiple nuclei, a behaviour typical of myotubes. Images in (h) and (i) (4× magnification) represent light microscopy images of l6 myoblasts treated with 
osteoblast-harvested bone active proteins after one and ten days, respectively. Panel (j) represents H and e-stained image of treated l6 cells. Inset in (j) repre-
sents uninucleated structure of myoblasts ten days following treatment with osteoblast proteins. 
 Fig. 6a Fig. 6b Fig. 6c Fig. 6d
 Fig. 6e Fig. 6f Fig. 6g
 Fig. 6h Fig. 6i Fig. 6j
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Cell viability and myotube number. No significant dif-
ference in proliferation profile of cells was observed 
(Fig.  7a). on the contrary, cells in the control groups 
fused to form myotubes with multiple nuclei. We also 
analysed the number of myotubes that could be observed 
over a period of seven days, as represented in Figure 7b. 
the number of myotubes in the control group increased 
over time (p < 0.05), however, in the treated group very 
few myotubes were observed on day 1 and the number 
reached zero after day 3, indicating complete suppres-
sion of myotube formation.
Osteoblast cell factory composition. We confirmed the 
presence of two of the most common osteoinductive 
proteins, bMP-2 and bMP-7, responsible for osteogenic 
differentiation of various mesenchymal cells into osteo-
blastic lineages. the detection of osteogenic proteins was 
performed using elISA and the respective concentrations 
of bMP-2 and bMP-7 in the cell media were 8.4 ng/mg 
(sd 0.8) and 50.6 ng/mg (sd 2.2) of the harvested protein 
fraction.
Discussion
We have observed that muscle tissue in direct contact 
with HA-cS and HA–cS-G biomaterials had shown signifi-
cant bone formation in a few clinical cases. to establish 
whether the biomaterial contributed to this phenomenon 
of bone formation, we have set up in vitro models to 
mimic the biological situations. We showed that an osteo-
promotive niche is provided by both HA-cS and HA-cS-G 
biomaterials, contributing to the differentiation of 
muscle cells towards an osteogenic lineage in vitro. 
Simultaneously, we harvested bone active proteins from 
multiplying bone cells in vitro and used them to differen-
tiate muscle cells into bone-like cells. In clinical studies, it 
has been reported that when HA-cS or HA-cS-G is used 
to fill a bone defect, new bone is formed locally.32 
However, new bone formation in the muscle in direct 
contact with the biomaterials was unforeseen and led us 
to explore the material behaviour with muscle cells. We 
also considered the possibility of growth factors and extra 
cellular matrix proteins released from the underlying 
bone cavity and acting synergistically with HA-cS and 
HA-cS-G. the perivascular niche in the muscle has stem 
cells and their recruitment to the underlying bone and 
the biomaterial is highly likely.
We have observed clinically extensive bone formation 
in the muscle surrounding HA-cS and HA-cS-G biomate-
rial as early as six weeks after surgery. Hydroxyapatite-
based scaffolds have been known to induce bone 
formation in the muscle when used alone in larger ani-
mal models, thus corroborating well with our observa-
tions.33 However, the amount of time required for 
mineralisation in ectopic sites has always been longer 
than that which we have observed in our clinical case. In 
our opinion, this is an additional effect observed due to 
the presence of a ceramic matrix and bone active proteins 
leaking out of the bone cavity. Moreover, we have also 
observed resorption of the bone formed in the muscle 
five months post-operatively when compared with six 
weeks as observed from the images in Figures 1e and 1f. 
this might be because muscle is unloaded when com-
pared with bone which leads to resorption.34 A similar 
phenomenon has also been observed in the osteomyelitis 
case (Fig. 2).
Upon physiochemically characterising the biomateri-
als using scanning electron microscopy (SeM), we veri-
fied the porous structure (Figs 3a and 3b). It has already 
been reported that heterotopic bone formation was 
induced in the presence of micropores in ceramic materi-
als.35,36 Porous HA-cS and HA-cS-G scaffolds provide suf-
ficient surface area for cellular attachment and also an 
efficient environment for exchange of nutrients, gases 
and other signalling molecules. cells were uniformly dis-
tributed across the surface of the scaffold as observed 
from SeM and DAPI analysis (Figs 3c to 3f). one notewor-
thy observation is the morphology of c2c12 cells when 
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cellular proliferation was assessed via 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide assay (a). Myotube number/well in both groups was 
counted using light microscopy (b). Statistical analysis was performed using multiple t-tests; ** indicates p < 0.01 and *** represents p < 0.001. Data are repre-
sented as mean and standard deviation and the samples were taken in triplicate (n = 3).
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seeded on HA-cS and HA-cS-G surfaces. We have, in 
our previous work, reported that when c2c12 myoblasts 
are seeded on elastic biomaterials, they tend to form 
elongated myotubes, which in the current scenario is not 
seen.37 this led us to consider other phenotyping meth-
ods to understand changes in the skeletal muscle cell line 
c2c12. the cellular proliferation was similar on both the 
scaffolds with and without gentamicin, indicating that 
the addition of gentamicin to the scaffold in our model 
does not cause toxicity in the cells (Fig. 4a). the scaffolds 
exhibited a gradual but suppressed proliferation of 
c2c12 muscle myoblasts when compared with tissue 
culture plates. However, this difference in the prolifera-
tion behaviour of cells on HA-cS and HA-cS-G discs and 
2D tissue culture plate might be due to differentiation of 
myoblast c2c12 cells to osteoblast lineage. It has been 
shown that the proliferation of cells is arrested during its 
differentiation.36,38,39 AlP is an important osteogenic 
marker, and an eightfold increase in the AlP activity 
(Fig. 4b) in the cells seeded on the discs of HA-cS and 
HA-cS-G clearly demonstrated the osteopromotive 
behaviour of the material, irrespective of whether gen-
tamicin was added. this was the result of the c2c12 cells 
that differentiated into osteoblasts, entering into matura-
tion phase. AlP also acts as an osteogenic cell formation 
predictor.40-43 cells seeded on a 2D polystyrene tissue 
culture plate showed lower values of AlP activity com-
pared with that of the biomaterial discs (Fig. 4b). We 
observed the presence of prominent osteogenic markers 
such as rUNX2, col 1, ocN and oPN in cells seeded on 
HA-cS discs. rUNX2 is reported as an osteoblast-specific 
transcription factor and a regulator of differentiation of 
osteoblasts.21,44,45 the presence of other markers of 
mature osteoblasts such as ocN, col I and oPN (Fig. 5a) 
was detected by the 21st day of cell seeding. Pcr results 
confirmed the gene expression of rUNX2, col 1, ocN 
and bSP in the cells seeded on HA-cS, thus confirming 
the osteopromotive potential of HA-cS (Figs 5b and 5c).
Another important aspect of our study was to address 
whether leaking bone active proteins from an open bone 
defect could induce bone formation both locally and in 
the muscle, as we observed in clinical cases. to address 
this question, the in vitro model closely simulates the in 
vivo situation by harvesting bone active proteins from an 
osteoblast cell line roS 17/2.8 and observing their effect 
on muscle myoblast cell line l6. by microscopic analysis 
(phase contrast and H and e staining), we observed uni-
nuclear and round morphology of cells over the course of 
12 days in the case of the treated cells while the cells in 
the controls fused together to form myotubes with a sig-
nificantly higher number than in the experimental group 
(p < 0.05), a behaviour typical of myoblasts (Fig. 7b). 
Immunostaining of cells in the treated group confirmed 
the phenotype shift with cells positive for important oste-
oblastic markers such as col 1, ocN, oPN and bSP 
(Figs 6a to 6d). the results are completely in accordance 
with earlier studies that establish the potential of bMP-2 
and bMP-7 in differentiating skeletal muscle cells c2c12 
towards osteoblastic lineage.46,47 both bMP-2 and bMP-7 
can induce differentiation of skeletal muscle cells into 
bone in a dose- and time-dependent manner. We con-
firmed the presence of these two pro-osteogenic proteins 
in the harvested cell factory using elISA.
It has previously been reported that inflammatory fac-
tors such as tumour necrosis factor-α (tNF-α) secreted 
from a fracture site leads to differentiation of muscle cells.48 
Also tNF-α obtained from culturing fractured bone in vitro 
can lead to osteogenic differentiation of muscle cells. 
However, in our clinical observation, ectopic bone forma-
tion was uncommon in patients with regular surgical 
intervention and was specifically seen when the biomate-
rial was used. In this study we focused more on material 
properties and the role of leaking bone active proteins 
rather than looking at inflammatory factors and cytokines. 
thus, we have demonstrated a possible mechanism for 
bone formation in the muscle synergistically mediated by 
bone active proteins leaking from a bone defect and 
enhanced by HA-cS and HA-cS-G biomaterials.
In conclusion, in vitro studies performed with HA-cS 
and HA-cS-G biomaterials and muscle cell line c2c12 
clearly show the osteopromotive effect of the ceramic 
material. Strong resemblance to native bone (due to the 
hydroxyapatite mineral phase) and microporosity and 
surface topography leads to differentiation of muscle 
myoblast cells into osteogenic cells when in contact with 
the biomaterial. We have also confirmed that a cocktail of 
growth factors containing bMP-2, bMP-7 and other bone 
active proteins, derived from osteoblast cells, can be har-
vested and used in a facile manner. these harvested 
growth factors are also able to induce the differentiation 
of muscle cells into bone cells. the clinical observations 
suggest that HA-cS and HA-cS-G biomaterials can induce 
bone formation in an overlaying muscle due to the osteo-
promotive properties of the material. bone active pro-
teins leaking from a bone defect also have the potential 
for osteogenic differentiation. the biomaterial and the 
leaking growth factors can lead to recruitment and dif-
ferentiation of osteoprogenitor cells from the perivascular 
muscular niche to the material.
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